Advancing preclinical cancer models to assess clinically relevant outcomes

Cancer models are indispensable research tools for elucidating the mechanisms involved in tumor onset, progression and treatment resistance. They are key in evaluating therapeutics prior clinical trials. In this editorial, we invite contributions for a BMC Cancer’s Collection of articles addressing...

Descripción completa

Detalles Bibliográficos
Autores principales: Golebiewska, Anna, Fields, Ryan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007806/
https://www.ncbi.nlm.nih.gov/pubmed/36899363
http://dx.doi.org/10.1186/s12885-023-10715-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007806/
https://www.ncbi.nlm.nih.gov/pubmed/36899363
http://dx.doi.org/10.1186/s12885-023-10715-7

Ejemplares similares